Veuillez utiliser cette adresse pour citer ce document :
http://dspace1.univ-tlemcen.dz/handle/112/2491Affichage complet
| Élément Dublin Core | Valeur | Langue |
|---|---|---|
| dc.contributor.author | Griffiths, G | - |
| dc.contributor.author | Luger, T | - |
| dc.contributor.author | Brault, Y | - |
| dc.contributor.author | Germain, JM | - |
| dc.contributor.author | mallbris, L | - |
| dc.date.accessioned | 2013-07-13T10:56:03Z | - |
| dc.date.available | 2013-07-13T10:56:03Z | - |
| dc.date.issued | 2013 | - |
| dc.identifier.uri | http://dspace.univ-tlemcen.dz/handle/112/2491 | - |
| dc.description.abstract | A post hoc analysis of the randomised ; open -label , 54 - week multicentre CRYSTEL study showed pasients who achienved a clinical response ( physi cian global assessmen of psoriasis [PGA]<=2) on etanercept (ETN)50mg twice weekly (BIW) then paused treatement and subsequently relapsed (PGA)>2 were able to recapture the response after retreatement with ETN 25 mg BIW .in clinical practice , however , patient with (PGA <=1 (clear /almost clear ) are more likely to be candidates for | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | journal of the european academy of dermatology and venereology | en_US |
| dc.publisher | University of Tlemcen | en_US |
| dc.title | Retreatement in patients achie ving response after relapse due to trea tment interruption : results from the crystel study | en_US |
| dc.type | Article | en_US |
| Collection(s) : | Articles internationaux | |
Fichier(s) constituant ce document :
| Fichier | Description | Taille | Format | |
|---|---|---|---|---|
| retreatement-in--patients-achie-ving-response-after-relapse--due--to-trea-tment-interruption-:-results---from--the-crystel--study.pdf | 112,91 kB | Adobe PDF | Voir/Ouvrir |
Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.